Literature DB >> 28642672

Multifocal osteonecrosis secondary to occupational exposure to aluminum.

Jorge Henrique Assunção1, Eduardo Angeli Malavolta1, Mauro Emilio Conforto Gracitelli1, Renée Zon Filippi1, Arnaldo Amado Ferreira1.   

Abstract

Multifocal osteonecrosis is a rare disease; chronic use of corticosteroids is considered the main risk factor. Patients with chronic renal failure can develop aluminum toxicity, which can lead to osteomalacia and encephalopathy. An association between osteonecrosis and aluminum toxicity has been reported among patients with dialytic renal insufficiency. Occupational exposure to aluminum rarely causes lung disease and no cases of bone lesions resulting from exposure to this metal have been reported. In this manuscript, we describe a novel case of a patient with multifocal osteonecrosis associated with chronic occupational exposure to aluminum. Level of Evidence IV, Case Report.

Entities:  

Keywords:  Hip; Knee; Occupational injuries; Osteonecrosis; Shoulder

Year:  2017        PMID: 28642672      PMCID: PMC5474414          DOI: 10.1590/1413-785220172503170760

Source DB:  PubMed          Journal:  Acta Ortop Bras        ISSN: 1413-7852            Impact factor:   0.513


  20 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 2.  Complications associated with sickle cell trait: a brief narrative review.

Authors:  Geoffrey Tsaras; Amma Owusu-Ansah; Freda Owusua Boateng; Yaw Amoateng-Adjepong
Journal:  Am J Med       Date:  2009-04-24       Impact factor: 4.965

Review 3.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

Review 4.  Pathogenesis and natural history of osteonecrosis.

Authors:  Yehudith Assouline-Dayan; Christopher Chang; Adam Greenspan; Yehuda Shoenfeld; M Eric Gershwin
Journal:  Semin Arthritis Rheum       Date:  2002-10       Impact factor: 5.532

5.  [Testicular seminoma and multifocal aseptic osteonecrosis following chemotherapy].

Authors:  N Magné; C Foa; J N Bruneton; P Y Marcy
Journal:  Rev Med Interne       Date:  2001-01       Impact factor: 0.728

Review 6.  Osteonecrosis of the hip: treatment options and outcomes.

Authors:  Samik Banerjee; Kimona Issa; Robert Pivec; Bhaveen H Kapadia; Harpal S Khanuja; Michael A Mont
Journal:  Orthop Clin North Am       Date:  2013-08-26       Impact factor: 2.472

7.  Osteonecrosis in sickle cell trait.

Authors:  P W Taylor; W P Thorpe; M C Trueblood
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

Review 8.  A rare cause of peripheral arthralgia in inflammatory bowel disease: multifocal osteonecrosis.

Authors:  P C Grunert; F Collettini; C Perka; M Zeitz; B Wiedenmann; C Büning
Journal:  Z Gastroenterol       Date:  2014-03-12       Impact factor: 2.000

9.  Consequences of avascular necrosis of the femoral head in aluminium-related renal osteodystrophy and the role of endochondral ossification in the repair process.

Authors:  J McClure; P S Smith
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

Review 10.  High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature.

Authors:  Jose A Gómez-Puerta; Pilar Peris; Joan Carles Reverter; Gerard Espinosa; Angeles Martinez-Ferrer; Ana Monegal; Juan Monteagudo; Dolors Tàssies; Nuria Guañabens
Journal:  Medicine (Baltimore)       Date:  2013-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.